drugset
drugset / Trial / NCT06823895

Pharmacokinetic Study of Oligonucleotides in Maixuekang Capsules

NCT06823895 ↗

Phase 1 Recruiting 12 enrolled Nanfang Hospital, Southern Medical University
Non-randomizedParallel-groupOpen-labelBasic science

Summary

The objective of this clinical trial is to learn the sequence and expression level of Maixuekang oligonucleotides in the plasma of healthy volunteers. 1. Detecting the sequence and expression levels of oligonucleotides in the blood of healthy subjects before and after a single administration of Maixuekang at different time points. 2. Detecting the sequence and expression levels of oligonucleotides in the blood of healthy subjects before and after multiple administrations of Maixuekang at different time points. Single dose group: Participants will be given Maixuekang capsules once, 1g, orally. Multiple dose group: Participants will receive 1g of Maixuekang capsules orally for 3 days, 3 times a day.

Timeline

Start
2024-09-25
Primary completion
2026-12-31
Completion
2026-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Maixuekang capsule Unknown 1 g Oral

Indications

No indication recorded.